RANI — RANI THERAPEUTICS HLDGS INC

Ownership history in XTX Topco Ltd  ·  3 quarters on record

This page tracks every 13F SEC filing in which XTX Topco Ltd reported a position in RANI THERAPEUTICS HLDGS INC (RANI). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 44,077 +33,081 +300.8% 0.00% $22K $0.50
2025 Q1 REDUCED 10,996 -1,894 -14.7% 0.00% $14K $1.26
2024 Q4 INITIATED 12,890 — — 0.00% $18K $1.37
% of Fund (quarterly)    RANI price (monthly, adj. close)

Other funds also holding RANI

As of 2025 Q4 — sorted by position size

Samsara BioCapital, LLC 3Y 7Y 1.18% AWM Investment Company, Inc. 3Y 7Y 0.85% Nan Fung Group Holdings Ltd 3Y 0.6% Longaeva Partners L.P. 0.24% RA CAPITAL MANAGEMENT, L.P. 3Y 7Y 0.12% Siren, L.L.C. 0.08% 683 Capital Management, LLC 3Y 7Y 0.03% UNITED SERVICES AUTOMOBILE ASSOCIATION 3Y 7Y 0.03% Well Done, LLC 3Y 7Y 0.01% ACT Advisors, LLC. 3Y 0.01%
← Back to XTX Topco Ltd Holdings